Currently out of the existing stock ratings of Jacob Johnson, 109 are a BUY (78.42%), 30 are a HOLD (21.58%).
Analyst Jacob Johnson, has had 62.72% of price targets met with an average potential upside of 31.52%, reached in 164 days on average. Previously, Jacob Johnson worked at STEPHENS.
Jacob Johnson has documented 267 price targets and ratings displayed on 26 stocks. The coverage was on Healthcare, Technology, Industrials sectors.
Most recent stock forecast was given on STE, STERIS plc at 05-Feb-2025.
Analyst best performing recommendations are on LFCR (LIFECORE BIOMEDICAL).
The best stock recommendation documented was for CYRX (CRYOPORT) on 8/24/2020. The price target of $44 was fulfilled within 2 days with a profit of $7.32 (19.96%), with a performance score of 99.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Feb-2026
$52
$6.35 (13.91%)
$30
Buy Since 07-May-2021
$37
$-8.65 (-18.95%)
$37
2 months 1 days ago
(14-Sep-2026)
12/31 (38.71%)
$4.96 (15.48%)
171
Buy Since 05-Feb-2026
$35
$-10.65 (-23.33%)
$35
3 months 9 days ago
(06-Aug-2026)
12/14 (85.71%)
$4.26 (13.86%)
106
Hold Since 27-Feb-2025
$30
$-15.65 (-34.28%)
$39
9 months 11 days ago
(04-Feb-2026)
3/4 (75%)
$1.51 (5.30%)
20
Buy Since 25-Nov-2025
$45
$-0.65 (-1.42%)
$35
11 months 21 days ago
(25-Nov-2025)
2/2 (100%)
$6.9 (18.11%)
232
